Author:
Jin Chao-long,Shi Xue-gong,Wang Ting-ting,Li Hong-wen,Zhang Ding-Xin,Sheng Zhe,Xiao Jie,Yu Yong-Qiang
Abstract
Abstract
Background
Echocardiography (ECHO) and cardiac magnetic resonance imaging (MRI) are used to observe changes in the left ventricular structure in patients with breast and gastric cancer after 6 cycles of chemotherapy. Based on the observed values, we aimed to evaluate the cardiotoxicity of anthracyclines in cancer patients and to analyze the consistency of the two examination methods in assessing left ventricular function after chemotherapy.
Methods
From January 2020 to January 2022, the data of 80 patients with malignant tumors who received anthracycline chemotherapy (breast cancer, n = 40; gastric cancer, n = 40) and 40 healthy volunteers (Control group) were retrospectively collected. Serum high-sensitivity cardiac troponin T (hs-cTnT) levels were detected by an automatic immunoassay analyzer. Left ventricular end-systolic volume (LVESV), left ventricular end-diastolic volume (LVEDV) and left ventricular ejection fraction (LVEF) were measured by cardiac MRI and 2-dimensional ECHO using the biplane Simpson’s method.
Results
Compared with baseline values, serum high-sensitivity cardiac troponin T (hs-cTnT) levels were significantly increased in patients with breast cancer and gastric cancer after 6 cycles of chemotherapy (P < 0.05). In addition, LVEDV, LVESV and LVEF measured with MRI were higher than those detected by ECHO in cancer patients after 6 cycles of chemotherapy (P < 0.05). And the Bland-Altman plot analysis showed that LVEDV, LVESV and LVEF measured by the two examination methods were in good agreement.
Conclusion
Breast and gastric cancer patients exhibited elevated levels of hs-cTnT after 6 cycles of chemotherapy, indicating potential cardiotoxicity. Additionally, cardiac MRI and 2-dimensional ECHO showed good agreement in assessing left ventricular function, with ECHO tending to underestimate volume measurements compared to MRI.
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Reference24 articles.
1. Dagenais GR, Leong DP, Rangarajan S, et al. Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study. Lancet. 2020;395(10226):785–94.
2. Siegel RL, Miller KD, Fuchs HE, et al. Cancer Stat 2022 CA: cancer J Clin. 2022;72(1):7–33.
3. Gabani M, Castaneda D, Nguyen QM, et al. Association of Cardiotoxicity with Doxorubicin and Trastuzumab: a double-edged Sword in Chemotherapy. Cureus. 2021;13(9):e18194.
4. Zhang Y, Jiang ZR, Tain Y, et al. Real-time three-dimensional Speckle Tracking Imaging in Assessment of the impact of breast Cancer anthracycline-based Chemotherapy on Left ventricular function. Chin J Med Imaging. 2019;27(5):333–8.
5. Zhang W, Huang JY, Li H. Clinical application of three-dimensional speckle tracking imaging in evaluating left ventricular function in patients with gastric cancer after anthracycline chemotherapy. World Chin J Digestology. 2018;26(36):2127–32.